Clinical trial
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly…
NCT00355121 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00355121 |
|---|---|
| Title | Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® |
| Official title | Immunogenicity and Safety of Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Children Aged 4 to 6 Years in the US When Administered Concomitantly With a Fifth Dose Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Meningococcal Meningitis, Tetanus, Diphtheria, Pertussis, Poliomyelitis |
| Intervention type | Biological |
| Interventions | Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
| Enrollment | 882 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jul 21, 2006 |
| Last update posted | Aug 24, 2011 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: